AIM: To evaluate whether fat distribution plays a role in determining serum leptin concentrations. PATIENTS AND METHODS: One-hundred and forty-seven obese patients, 77 males and 70 females, aged 45.1 AE 13.2 y (mean AE s.d.; range 21 ± 73 y), with body mass index (BMI) ranging from 30 to 55 kgam 2 (mean 42.3 AE 5.9). Ultrasound assessment of the thickness of subcutaneous and preperitoneal fat was carried out and calculation of their ratio as abdominal fat index (AFI), waist ± hip ratio (WHR), body composition by bioelectrical impedance to evaluate the percentage of fat mass (FM%) and total amount of fat (FMKg) were also determined. Plasma leptin was measured by radio immuno assay (RIA). RESULTS: In the whole group of patients, serum leptin concentrations were 37.2 AE 18.4 ngaml (range 6 ± 101.3 ngaml); in spite of BMI values not being signi®cantly different, women had leptin values signi®cantly higher (47.4 AE 17.4 ngaml) (P`0.01) than males (28.1 AE 15.1 ngaml), also after correction for fat mass. The mean thickness of abdominal subcutaneous fat was 33.7 AE 12.9 mm and it was signi®cantly (P`0.001) higher in female (40.9 AE 10.6 mm) than in male (27.1 AE 11.2 mm) patients; preperitoneal thickness was 22.9 AE 7.1 mm, with signi®cantly (P`0.05) higher values in males (24.2 AE 6.8 mm) than in females (21.7 AE 7.3 mm). Accordingly, AFI (in all patients 0.84 AE 0.6) was signi®cantly higher in males (1.09 AE 0.6) than in females (0.56 AE 0.2). In the overall population, leptin concentrations were directly and signi®cantly related to subcutaneous but not preperitoneal fat; they showed a strong inverse relationship with AFI and WHR. When the results were evaluated dividing the patients according to gender, subcutaneous fat thickness showed a stronger association with leptin levels in males than in females, whereas no association was found with preperitoneal fat thickness. Leptin and AFI values were signi®cantly related only in men. WHR values were not correlated with leptin concentrations in either sex. When fat mass was added to the model, subcutaneous fat thickness, AFI and WHR remained independently associated with leptin concentrations. Age and diabetes did not in¯uence these measures. CONCLUSIONS: Fat distribution contributes to the variability in serum leptin in obese patients. In particular, subcutaneous abdominal fat is a determinant of leptin concentration, also independently of the amount of fat mass, whereas the contribution of preperitoneal visceral fat is not signi®cant.
Introduction
In the last few years a large number of studies have dealt with the determinants of leptin concentrations in physiological and pathological conditions. Although gender and the amount of body fat 1 ± 3 are strong contributors, it is clear that these two factors cannot fully explain the wide variability of hormone concentrations; indeed, similar levels of body mass index (BMI) have very different leptin levels. 4 ± 6 The data from clinical studies examining whether fat distribution plays a role in determining serum leptin concentrations have given con¯icting results. 7 ± 18 A recent review states that`further investigation is needed of leptin secretion in relation to fat distribution and the differing biological functions of the subcutaneous and intra-abdominal deposits in this regard'. 19 The aim of our study was to provide in vivo evidence to support the hypothesis based on in vitro data that subcutaneous fat synthesizes leptin more ef®ciently than visceral fat. 20, 21 The variability in serum leptin concentrations and the gender-related differences in hormone concentration could then also be explained by differences in the amount of a speci®c fat type.
For this reason we assessed the thickness of abdominal subcutaneous and of preperitoneal fat by ultrasound as well as other anthropometric parameters of fat distribution and related it to serum leptin concentration in a selected series of obese patients.
Materials and methods

Patients
The present study included 147 obese patients, 77 males and 70 females, aged 45.1 AE 13.2 y (meanAE s.d.; range 21 ± 73 y), with BMI ranging from 30 to 55 kgam 2 (mean 42.3 AE 5.9) referred to the Division of Endocrinology and Metabolic Diseases of S Giuseppe Hospital, Istituto Auxologico Italiano, for diagnostic or therapeutic problems related to obesity or its comorbidities. The patients were selected out of a larger series of patients attending the hospital in order to ensure a good match of BMI between males and females in order to eliminate a strong source of variability in serum leptin in obese patients. Twentyeight patients had type 2 diabetes (glycated haemoglobin 6, 4 AE 1.5%) controlled by diet alone or combined with oral hypoglycaemic drugs. None of the patients had concomitant severe renal, hepatic or cardiac disease. Patients with a history of abdominal surgery with scars capable of interfering with the measurement of abdominal fat and patients with relevant hepatomegaly were excluded from the study. None of the patients, except those with diabetes, were taking drugs capable of interfering with lipid or glucose metabolism; in particular none of the women of fertile age were on birth control pills. Body weight was stable for the last 4 weeks before study admission. The aim and the design of the study was approved by our internal ethics committee and informed consent was obtained from all patients.
The study protocol included the assessment of height, weight, abdominal and hip girth for determination of BMI and waist ± hip ratio (WHR) and, moreover, the evaluation of resting energy expenditure (REE) and body composition. Circulating leptin concentration was determined on a blood sample taken between 0800 and 0900 after an overnight fast.
Methods
The thickness of the subcutaneous fat layer (ScF) and preperitoneal fat layer (PrF) of the abdomen was measured using a real-time ultrasound scanner, equipped with a linear 7.5 MHz LA 13A transducer (Esaote AU4 Biomedica Spa, Genova, Italy) according to Suzuki et al. 22 All the measurements were carried out by a single experienced operator; subjects were evaluated in the supine position, without speci®c bowel preparation, within 3 days of admission to the hospital. The linear-array probe was kept perpendicular to the skin on the upper median abdomen during longitudinal scanning from the xiphoid process to the navel along the linea alba. Each measurement was performed avoiding compression of the abdominal wall by the transducer. The distance from the inner surface of subcutaneous tissue to the linea alba and the distance from linea alba to the peritoneum were measured directly with electronic calipers in proximity to the left lobe of the liver, and their ratio was calculated and termed the abdominal fat index (AFI). A convex-array probe (3.75 MHz) was also used for comparison with values obtained with a linear-array probe in the same cases. The coef®cients of variation obtained in a group of 21 patients evaluated ®ve times for each subject for S and P values were, respectively, 3.0% (range 1.24 ± 6.58%) and 4.2% (range 0.86 ± 7.75%).
Total body fat mass (FM kg) and the percentage of fat body weight (FM%), total body fat-free mass (FFM kg) and percentage of fat-free mass (FFM%) were determined by bioelectrical impedance analysis method (BIA 101aS Akern, Firenze, Italy) in the morning, after an overnight fast and after voiding.
Body fat distribution was also assessed by measuring waist and hip circumference and by calculating their ratio (WHR). The waist circumference was taken to the smallest standing horizontal circumference between ribs and the iliac crest; the hip circumference was taken as the largest standing horizontal circumference of the buttocks.
Serum leptin concentrations were measured by radioimmunoassay using reagents supplied by Linco Research Inc. (St Louis, MO, USA). In this assay, the detection limit was 0.15 ngaml; the intra assay precision (CV%) was 2.2% (6 ngaml), 2.7% (25 ngaml), and 5.9% (62.8 ngaml); the inter-assay precision from 10 different runs of three patients, serum samples was 4.3%, 4%, and 6.9% at concentrations of 5.1, 21 and 56.2 ngaml, respectively. In 32 lean subjects (BMI 18 ± 25 kgam 2 ), reference limits (2.5 ± 97.5 percentiles) were 0.98 ± 5.17 ngaml in men and 2.6 ± 17.4 ngaml in women.
Statistical analysis
The statistical analysis of the results was performed by SPSS software package. Variables not normally distributed were analysed after log transformation. The relationships between leptin and the other variables were assessed by linear regression with leptin as the dependent variable.
Results
The demographic, clinical and anthropometric data of the patients are reported in Table 1 . In the whole group of patients, serum leptin concentration were 37.2 AE 18.4 ngaml (range 6.2 ± 101.3 ngaml); in spite of similar BMI values, women had leptin values signi®cantly higher (47.4AE 17.4 ngaml; P`0.01) than men (28.1 AE 15.1 ngaml), even after correction for fat mass. The WHR was 0.95AE 0.01 in the whole group of patients, women showing signi®cantly lower (P`0.001) values (0.86AE 0.06) than men (1.01 AE 0.06).
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The mean thickness of abdominal subcutaneous fat was 33.7AE 12.9 mm and it was signi®cantly (P`0.001) higher in female (40.9 AE 10.6 mm) than in male (27.1 AE 11.2 mm) patients; conversely, preperitoneal thickness was signi®cantly (P`0.05) higher in males (24.2 AE 6.8 mm) than in females (21.7 AE 7.3 mm). Accordingly, the ratio between preperitoneal and subcutaneous fat (in all patients 0.84AE 0.6) was signi®cantly (P`0.001) higher in males (1.09 AE 0.6) than in females (0.56 AE 0.2).
In a single regression model (Table 2) , leptin concentrations were signi®cantly and directly related to both BMI and body fat values, expressed either as percentage or kg of fat mass and inversely correlated with WHR. Leptin concentrations were also directly and signi®cantly related to subcutaneous, but not preperitoneal fat thickness; they showed a strong inverse relationship with AFI.
When the data were separately analysed for males and females, subcutaneous fat thickness showed a stronger association with leptin concentrations in males than in females (Figure 1 ), whereas no association was found with preperitoneal fat thickness in either sex (Figure 2 ). Leptin and AFI values were signi®cantly related only in men (Figure 3) . WHR values were not related to leptin concentrations in either sex (Figure 4) , although an inverse correlation was present in the overall series. Age had no effect on these measures and in particular the relationships of leptin with subcutaneous or preperitoneal fat thickness adjusted for fat mass were not different in the subset of the 30 women who were post-menopause. 
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In a multiple regression analysis including fat mass, subcutaneous fat thickness, AFI and WHR remained independently associated to leptin concentrations (Table 2 ) and these relationships were similar in the diabetic and non-diabetic groups.
Discussion
Our data gives further evidence that fat either expressed as a percentage of body mass or as an absolute amount is a major determinant of leptin concentrations and that hormone levels are higher in women than in men, also when values of BMI are similar and the degree of adiposity is considered both as percentage or as an absolute value of fat mass.
However adiposity and gender can account only partially for serum leptin concentrations in obese patients and other factors play a role in explaining the high variability of plasma leptin concentrations, even when they are considered in relation to a given level of body fat. Indeed, a relevant contribution to the peripheral plasma pool of leptin by an active secretion by the brain has been recently demonstrated. 23 The results of this study carried out by ultrasound show that the thickness of abdominal subcutaneous tissue of obese women is greater in women than in men of comparable BMI, despite higher absolute amounts of total body fat, whereas that of preperitoneal fat is smaller; our study is in agreement with results from Suzuki et al 22 and by Shimizu et al 17 showing that ultrasound is a reliable approach to measuring the thickness of abdominal subcutaneous tissue and of a speci®c portion of intra-abdominal fat. Moreover, in markedly obese patients the method we have adopted seems to have an advantage over the method by Armellini et al, 24 which instead requires pressure on the abdominal wall in order to visualize the aorta. The data we have obtained by this approach support the view of a relationship between plasma leptin and regional fat accumulation, since we found a very strong relationship between leptin levels and subcutaneous but not preperitoneal fat thickness. The relation between leptin and subcutaneous tissue persisted, although weaker, also when adiposity, expressed as kilogrammes of fat mass, was included in the model. This seems in agreement with the data of Van Harmelen et al, 25 showing that subcutaneous adipose tissue secretes more leptin than the omental compartment, even when secretion rate was related to the number of cells. Thus, the contribution of subcutaneous fat in secreting leptin is attributable both to its predominant mass, since visceral fat is only 5 ± 10% of total fat mass, 26 and to its higher releasing activity per fat cell.
Evidence has been provided of the heterogeneity of regional fat in producing leptin, since increased expression of OB mRNA has been detected in subcutaneous as compared with intra-abdominal adipose tissue; 27 moreover it has been shown that subcutaneous fat releases more leptin than omental both in obese and in normal women. However, in adipocytes of non-obese men no differences were found in leptin secretion between the two types of fat. 28 The data of clinical studies relating serum leptin and fat distribution in obese patients are in con¯ict: further studies employing anthropometric measures and dual energy X-ray absorptiometry 10 concluded that plasma leptin is dependent only on total fat and not on its distribution; in other studies 12 the ®nding of a correlation between leptin and WHR suggested that leptin is associated more with the peripheral depot than with visceral fat.
Studies employing computed tomography found either a relationship with both subcutaneous and Figure 3 Simple regression between unadjusted serum leptin and AFI index, ie ratio between preperitoneal and subcutaneous fat thickness measured by ultrasound in 147 obese patients. Figure 4 Simple regression between unadjusted serum leptin waist ± hip ratio in 147 obese patients.
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A Minocci et al visceral 14 or with subcutaneous tissue alone; 7, 13 in other studies no relationship was found between leptin and fat distribution. 9, 11, 16 The results of our study are partially at variance with those obtained by Shimizu et al 17 using the same ultrasonographic method in a series of 104 lean healthy subjects. They conclude that serum leptin levels are related to total fat mass but do not re¯ect fat distribution. An explanation for this discrepancy is not readily available, but differences in the regional secretion of leptin between normal and obese patients may be considered.
More recently, Rissanen et al, 29 using the ultrasonographic method by Armellini et al 24 did not ®nd a relationship between the thickness of abdominal subcutaneous fat and that of visceral fat in a series of 38 patients with moderate obesity; the relationship became signi®cant after weight loss, although the reasons for this latter ®nding are not easily explained.
In considering our data on fat distribution according to gender, the absence of signi®cant relationship between leptin and preperitoneal fat demonstrates that in both sexes this fat depot does not contribute signi®cantly to the variability of leptin levels, whereas the stronger relationship with subcutaneous fat in males may indicate that in females the secretion of leptin for cell unit may be more variable; alternatively other sources, such as the brain, may be more important in determining leptin levels in females than in males, as demonstrated by Wiesner et al. 23 These results are in agreement with those reported by Wauters et al 18 in male and female obese patients who were, however, not well matched for number of subjects in each group and for BMI.
Actually, the reasons for the higher levels of leptin in women than in men is still unclear since the sexrelated differences in amount of subcutaneous or visceral adipose tissue are important but cannot fully account for the sexual dimorphism of serum leptin. 30 Age did not in¯uence the relationship between leptin and the parameters of fat distribution either in males or in females in accordance with our previously published data, suggesting that excess of body fat may prevent the decline of plasma leptin associated with aging in non-obese subjects. 31, 32 Moreover, we did not ®nd differences in the results when the subset of diabetic patients was separately considered; a ®nding in accordance with reports in literature showing that diabetes, unless decompensated, does not affect leptin levels and the relationship of leptin and BMI. 33, 34 The ratio between preperitoneal and subcutaneous fat thickness Ð the AFI Ð has been considered as a good indicator of visceral fat deposition by Suzuki et al 22 but not by Shimizu et al. 17 Our data show that AFI is a good and negative predictor of leptin levels with the same strength as WHR when the whole group of patients is considered (Table 2) ; when males and females are separate, AFI maintains its predictive values in males only, while the correlation with WHR is lost.
Collectively, the data obtained by this ultrasound method of assessment of thickness of abdominal subcutaneous and preperitoneal fat indicate the existence of a relationship between leptin and regional fat distribution in obese patients; in particular, they show that subcutaneous but not visceral preperitoneal fat contributes to the variability of circulating levels of leptin. Our results suggest that the higher leptin concentrations in women may, at least partially, be explained by more subcutaneous fat. However, other still unidenti®ed factors are likely to play a role in determining the gender-related variability of serum leptin concentrations at comparable levels of body and fat mass.
